At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PGNY Progyny
Closed 04-22 16:00:00 EDT
17.99
-0.03
-0.17%
盘后17.98
-0.01-0.06%
18:46 EDT
High18.12Low17.51Vol1.48M
Open18.02D1 Closing18.02Amplitude3.39%
Mkt Cap1.41BTradable Cap1.29BTotal Shares78.33M
T/O26.32MT/O Rate2.06%Tradable Shares71.67M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

A Look At Progyny (PGNY) Valuation After The Launch Of Progyny Select For Small Employers
Simply Wall St.  ·  04-18
A Look At Progyny (PGNY) Valuation After The Launch Of Progyny Select For Small Employers
Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan
GlobeNewswire  ·  04-16
Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan
A Look At Progyny (PGNY) Valuation After A Steep Three Month Share Price Pullback
Simply Wall St.  ·  04-04
A Look At Progyny (PGNY) Valuation After A Steep Three Month Share Price Pullback
Progyny hosts webinar on fertility and family-building options, mental health support
Reuters  ·  04-04
Progyny hosts webinar on fertility and family-building options, mental health support
Progyny to join NASDAQ closing bell ceremony for infertility awareness week
Reuters  ·  04-01
Progyny to join NASDAQ closing bell ceremony for infertility awareness week
Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care
GlobeNewswire  ·  04-01
Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care
Progyny announces annual shareholder meeting via preliminary proxy statement
Reuters  ·  04-01
Progyny announces annual shareholder meeting via preliminary proxy statement
Progyny Is Maintained at Overweight by Barclays
Dow Jones  ·  03-20
Progyny Is Maintained at Overweight by Barclays
Progyny price target lowered to $23 from $29 at Barclays
TIPRANKS  ·  03-20
Progyny price target lowered to $23 from $29 at Barclays
Assessing Progyny (PGNY) Valuation After Prolonged Share Price Weakness
Simply Wall St.  ·  03-18
Assessing Progyny (PGNY) Valuation After Prolonged Share Price Weakness
BRIEF-Progyny Issues Notice Of Pendency Of Settlement Of Derivative Action
Reuters  ·  03-14
BRIEF-Progyny Issues Notice Of Pendency Of Settlement Of Derivative Action
Progyny Announces Settlement, Governance Reforms on Director Pay
TIPRANKS  ·  03-14
Progyny Announces Settlement, Governance Reforms on Director Pay
Progyny Inc - on March 13, Issues Notice of Pendency of Settlement of Derivative Action - SEC Filing
THOMSON REUTERS  ·  03-14
Progyny Inc - on March 13, Issues Notice of Pendency of Settlement of Derivative Action - SEC Filing
Progyny Is Maintained at Hold by Canaccord Genuity
Dow Jones  ·  03-12
Progyny Is Maintained at Hold by Canaccord Genuity
Progyny price target lowered to $19 from $26 at Canaccord
TIPRANKS  ·  03-11
Progyny price target lowered to $19 from $26 at Canaccord
Progyny (PGNY) Receives a Hold from Canaccord Genuity
TIPRANKS  ·  03-11
Progyny (PGNY) Receives a Hold from Canaccord Genuity
U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle
Reuters  ·  03-11
U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle
Progyny’s Dual Use of Buybacks and ESOP Shares Raises a Key Capital Allocation Question (PGNY)
Simply Wall St.  ·  03-11
Progyny’s Dual Use of Buybacks and ESOP Shares Raises a Key Capital Allocation Question (PGNY)
**Progyny executives to join March investor conferences**Progyny said its leadership team will participate in the Leerink Partners Global Healthcare Conference, the Barclays Global Healthcare Conference and the KeyBanc Capital Markets Healthcare Forum
Reuters  ·  03-06
**Progyny executives to join March investor conferences**Progyny said its leadership team will participate in the Leerink Partners Global Healthcare Conference, the Barclays Global Healthcare Conference and the KeyBanc Capital Markets Healthcare Forum
Progyny Is Maintained at Buy by BTIG
Dow Jones  ·  03-06
Progyny Is Maintained at Buy by BTIG

Introduction

Company Name.
Progyny
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Issue price:
--